There were no significant differences in AAA growth among the compared groups (P-score probability in brackets): propranolol (0.73), telmisartan (0.66), antibiotics (0.53), placebo (0.53), ACE inhibitors (0.52), ticagrelor (0.46), and pemirolast (0.06). Here, ACE is linked to triple-A syndrome.